MPH Health Care AG Overview
Pro stress-test →MPH Health Care AG operates as an investment company focused on the purchase, development, and sale of companies and shares in growth segments of the healthcare markets. The company operates Beauty, Pharma, and Real Estate segments, offering medical-aesthetic beauty operations and treatments as well as pharmaceuticals and medical products in therapeutic areas including oncology, HIV/AIDS, neurology, and rheumatology.
Strategic Profile
Pro stress-test →MPH's business activities consist of investing in companies with the aim of capital appreciation, with strategic focus on acquisition and development of companies particularly in growth segments of the healthcare market and pharmaceutical industry. The portfolio comprises HAEMATO AG (pharmaceutical generics), M1 Kliniken AG (aesthetic medicine), and MPH Ventures (venture capital in cytostatic solutions and real estate).
Competitive Landscape
Pro stress-test →HAEMATO AG offers cancer and chronic disease generics, while M1 Kliniken AG dominates the medicinal beauty and aesthetic surgery market with pharmaceutical products and medical devices. Primary competitors include larger German pharmaceutical holding companies and pan-European specialty pharma groups.
Industry Context
MPH Health Care AG operates in Healthcare Investment & Pharmaceuticals (Asset Management).
Key facts
Founded: 2008 · Headquarters: Berlin, Germany · Employees: 2 · Revenue: 34.43M EUR (2023) · Market cap: ~77M EUR